Insurers Try to Combat Drug Cos.' Marketing Clout

The countdown to Brandweek is on! Join us, Sept. 12-16, to identify new growth opportunities, solve challenges and connect with power players. View the lineup and secure your pass.



NEW YORK — Pharmaceutical makers spend billions of dollars a year to advertise their name brands, and to counter that clout, some health insurers are more aggressively trying to switch patients to cheaper medicines.

Insurers are writing letters to consumers and doctors, asking them to reconsider their prescription choices and call their attention to cheaper alternatives.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in